politics

Ester Baiget Reflects on Her Unexpected Journey to Novonesis CEO

23 Haziran 2026CNBC

Ester Baiget, the CEO of Novozymes, shares her journey from a 25-year career at Dow to leading a future bioscience giant. Her decision was driven by a desire to make an impact rather than personal ambition.
Baiget emphasizes the importance of family values in her leadership style and discusses the company's transformation into a leader in biosolutions, alongside the implications of the Chr. Hansen merger.
The bioscience industry is rapidly evolving, with companies increasingly focusing on sustainability and innovative solutions. Baiget's leadership at Novozymes comes at a pivotal time as the company seeks to redefine its role in this competitive market.
Baiget's transition from Dow to Novozymes illustrates a growing trend in corporate leadership where purpose and impact take precedence over traditional career ambitions. Her focus on values and long-term vision may serve as a blueprint for future leaders who aim to navigate the complexities of modern business while…

NewsAI özeti

This article is for informational purposes only and does not constitute financial or investment advice.